For 22-year-old Jacob Rosenberg, life without his daily dose of Vicodin wouldn't be much of a life at all. "Before I began taking narcotics two years ago, I would spend my days in bed," said Rosenberg, who has suffered from fibromyalgia ...Read More
Simvastatin is taken by around three million people in order to lower their cholesterol and reduce the risk of having a heart attack.
However an analysis of clinical trial data in America has found that high doses can cause muscle damage ...Read More
ZURICH (Dow Jones)--Roche Holding AG's (RHHBY) recent drug trial failures involving some of its most potent products have increased pressure on the Swiss firm ahead of its investor day on whether it can meet market hopes to turn into the ...Read More
Corey Haim died in Los Angeles in the early hours of Wednesday morning, and while an investigation is underway to determine the cause of death, the LAPD suspects an accidental drug overdose.
According to the coroner, four prescription drug bottles were ...Read More
ZURICH (Reuters) – Swiss drugmaker Roche Holding AG and U.S. biotechnology company Biogen Idec are suspending experimental rheumatoid arthritis and lupus treatment ocrelizumab after deaths following its use, casting doubt over its future. Roche and Biogen stopped using the experimental drug ...Read More
BASEL, SWITZERLAND - Swiss pharmaceutical company Roche Group said Monday it has suspended a late-stage trial for a new rheumatoid arthritis and lupus drug after several patients died from infections. Roche said the drug, ocrelizumab, was developed together with Biogen Idec ...Read More
ZURICH--Roche Holding AG and Biogen Idec Inc. said Monday they suspended a rheumatoid arthritis program using drug candidate ocrelizumab because of safety concerns, further cutting the experimental drug's market potential. The suspension was recommended by the independent Data and Safety Monitoring ...Read More
WASHINGTON (Reuters) - A daily dose of peanut powder could help some children who are allergic to peanuts, according to a pair of U.S. studies that confirm earlier findings, offering hope that a treatment could come soon. In one study, teams ...Read More
Simon Monjack tells UsMagazine.com it wasn't easy for him to read his late wife Brittany Murphy's final autopsy report, which was released Thursday.
He says he and the actress' mother Sharon "both sobbed and sobbed. I haven't gotten out of bed ...Read More
WASHINGTON (Dow Jones)--The Food and Drug Administration Thursday expanded the approval of the drug Rituxan to treat certain patients with chronic lymphocytic leukemia, a type of blood cancer. Rituxan, is made by Roche Holding AG's (ROG.VX) U.S.-based Genentech unit and is ...Read More
People with a positive outlook, who experienced joy, happiness, excitement and contentment in their lives were less likely to suffer heart disease, the study found. The researchers suggested it may be possible to help prevent heart disease by boosting people's positive ...Read More
(Health.com) -- A simple blood test may allow doctors to identify a debilitating form of arthritis years before any symptoms appear, which may help to stop the disease in its tracks, new research suggests. Rheumatoid arthritis (RA), which affects an estimated ...Read More
A simple blood test may soon help predict rheumatoid arthritis even before symptoms arise, say researchers. Rheumatoid arthritis is a chronic autoimmune disease characterized by joint inflammation involving the synovial (lubricating fluid of the joints) tissue and eventually leading to destruction ...Read More
WALTHAM, Mass.-Repligen Corp. said Thursday it extended its long-term deal to supply recombinant protein A to General Electric's GE Healthcare unit. Repligen said it entered into a five-year deal to supply the product. Recombinant protein A is used in the process ...Read More
WASHINGTON, Jan. 26 (UPI) -- The U.S. Food and Drug Administration says it has approved a morphine sulfate oral solution to treat moderate to severe pain in opioid-tolerant patients. The FDA said the medicine has been used for many years to ...Read More
Jan. 21, 2010 -- Swapping out the usual OJ for blueberry juice in the morning may give your brain a memory boost. A new study shows that drinking a daily dose of wild blueberry juice improved the memory of older adults ...Read More
Blood analysis systems company Abaxis Inc. said Thursday it received marketing approval for a test designed to detect infections and inflammatory diseases like rheumatoid arthritis. Abaxis said the Food and Drug Administration cleared its C-Reactive Protein assay, which is designed to ...Read More
Jan. 19, 2010 -- Overdoses and drug-related deaths are not uncommon among people taking opioid drugs that have been prescribed by a doctor for chronic pain, a new government-funded study finds. The finding suggests an urgent need to more closely monitor ...Read More
BusinessWire - Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA(R) (tocilizumab) for the treatment of adult patients with moderately to severely ...Read More
Eli Lilly & Co. said Friday Cymbalta reduced pain over 41 weeks for patients with chronic lower back pain, as the drugmaker again tries to gain Food and Drug Administration approval for the new use. In an extension study involving 181 ...Read More
